|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2004-9-14
|
|
pubmed:abstractText |
The modulation of fluorouracil (FU) by folinic acid (leucovorin [LV]) has been shown to be effective in terms of tumor response rate in patients with advanced colorectal cancer, but a meta-analysis of nine trials previously published by our group failed to demonstrate a statistically significant survival difference between FU and FU-LV. We present an update of the meta-analysis, with a longer follow-up and the inclusion of 10 newer trials.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3766-75
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15365073-Aged,
pubmed-meshheading:15365073-Antimetabolites, Antineoplastic,
pubmed-meshheading:15365073-Colorectal Neoplasms,
pubmed-meshheading:15365073-Female,
pubmed-meshheading:15365073-Fluorouracil,
pubmed-meshheading:15365073-Humans,
pubmed-meshheading:15365073-Leucovorin,
pubmed-meshheading:15365073-Male,
pubmed-meshheading:15365073-Middle Aged,
pubmed-meshheading:15365073-Prognosis,
pubmed-meshheading:15365073-Randomized Controlled Trials as Topic,
pubmed-meshheading:15365073-Survival Analysis,
pubmed-meshheading:15365073-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
|
|
pubmed:affiliation |
Saint Luc Hospital, Ireland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
